Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript

• click to rate

  Posted by Two Blokes Tue at 2:30 AM - Filed in Stock - 2 views
  
  Sangamo Therapeutics, Inc. (NASDAQGMO ) Q1 2025 Earnings Conference Call May 12, 2025 6:30 PM ET Company Participants Louise Wilkie - Vice President, Investor Relations and Corporate Communications Sandy Macrae - Chief Executive Officer Nathalie Dubois-Stringfellow - Chief Development Officer Prathyusha Duraibabu - Chief Financial Officer Conference Call Participants Nicole Germino - Truist Luis Santos - H.C. Wainwright Operator Good afternoon and welcome to the Sangamo Therapeutics First Quarter 2025 Teleconference Call.